rs35599367
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_017460.6(CYP3A4):c.522-191C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0317 in 152,126 control chromosomes in the GnomAD database, including 95 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.032 ( 95 hom., cov: 32)
Consequence
CYP3A4
NM_017460.6 intron
NM_017460.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.53
Publications
352 publications found
Genes affected
CYP3A4 (HGNC:2637): (cytochrome P450 family 3 subfamily A member 4) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020]
CYP3A4 Gene-Disease associations (from GenCC):
- vitamin D-dependent rickets, type 3Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0317 (4825/152126) while in subpopulation NFE AF = 0.0492 (3348/67990). AF 95% confidence interval is 0.0479. There are 95 homozygotes in GnomAd4. There are 2325 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 4825 Unknown,AD gene.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CYP3A4 | ENST00000651514.1 | c.522-191C>T | intron_variant | Intron 6 of 12 | NM_017460.6 | ENSP00000498939.1 | ||||
| CYP3A4 | ENST00000336411.7 | c.522-191C>T | intron_variant | Intron 6 of 13 | 1 | ENSP00000337915.3 | ||||
| CYP3A4 | ENST00000652018.1 | c.375-191C>T | intron_variant | Intron 4 of 10 | ENSP00000498733.1 | |||||
| CYP3A4 | ENST00000354593.6 | c.72-191C>T | intron_variant | Intron 1 of 7 | 5 | ENSP00000346607.2 |
Frequencies
GnomAD3 genomes AF: 0.0317 AC: 4824AN: 152008Hom.: 95 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
4824
AN:
152008
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0317 AC: 4825AN: 152126Hom.: 95 Cov.: 32 AF XY: 0.0313 AC XY: 2325AN XY: 74376 show subpopulations
GnomAD4 genome
AF:
AC:
4825
AN:
152126
Hom.:
Cov.:
32
AF XY:
AC XY:
2325
AN XY:
74376
show subpopulations
African (AFR)
AF:
AC:
364
AN:
41506
American (AMR)
AF:
AC:
389
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
202
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5178
South Asian (SAS)
AF:
AC:
44
AN:
4810
European-Finnish (FIN)
AF:
AC:
376
AN:
10578
Middle Eastern (MID)
AF:
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3348
AN:
67990
Other (OTH)
AF:
AC:
48
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
234
468
702
936
1170
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
24
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.